A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin

Clinical trial NCT02392130 · COMPLETED

Trial details

NCT number: NCT02392130
Sponsor: LEO Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Skin Tissue Diseases Connective Tissue Diseases

Start date: 2015-03-01
Primary completion: 2015-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.